feed,title,long_url,short_url
BioRxiv,Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like Betacoronaviruses,https://www.biorxiv.org/content/10.1101/2025.11.28.691177v1?rss=1,
BioRxiv,SARS-CoV-2 Spike Peptides Trigger Nociceptive Responses Through Spinal TLR4 Pathways,https://www.biorxiv.org/content/10.1101/2025.12.01.691535v1?rss=1,
